Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Danaher (0R2B) Price & Analysis

0R2B Stock Chart & Stats

$231.55-$3.84(-1.63%)
At close: 4:00 PM EDT
$200$210$220$2303 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$230.68 - $244.00
52-Week Range
$159.95 - $244.50
Previous Close
$235.38
Volume
3,548
Average Volume (3M)
1,483
Market Cap
$163.38B
Enterprise Value
$180.78B
Total Cash (Recent Filing)
$5.68B
Total Debt (Recent Filing)
$26.48B
Price to Earnings (P/E)
37.9
Beta
1.07
Next Earnings
Jan 27, 2027
EPS Estimate
2.48
Next Dividend Ex-Date
N/A
Dividend Yield
0.66%

Bulls Say, Bears Say

Bulls Say

Strong Cash Generation

Danaher’s substantial operating and free cash flow provides internal funding for innovation, acquisitions, debt service, and shareholder returns. Strong conversion of earnings into cash also supports resilience through cyclical laboratory and bioprocessing demand, while reducing reliance on external financing.

Recurring Consumables And Services Model

Danaher combines instruments with recurring consumables, reagents, software, and aftermarket services. This installed-base model deepens customer relationships, creates repeat purchasing, and can make revenue more durable than a business dependent only on episodic capital-equipment sales.

AI And Automation Platform Expansion

The autonomous-lab initiative broadens Danaher’s role from selling individual tools to enabling integrated research workflows. Combining instruments, consumables, robotics, software, and AI could improve customer productivity, increase platform pull-through, and create durable differentiation in scientific automation.

Bears Say

Respiratory Revenue Volatility

Respiratory exposure remains a meaningful source of revenue volatility because demand is influenced by infection rates and flu-season variability. Continued weakness can suppress Diagnostics growth and make consolidated performance less representative of underlying trends in other businesses.

Modest Growth And Lower Profitability

Recent growth has not fully reflected the portfolio’s potential, and profitability remains below prior peak levels. A slower revenue trajectory can limit operating leverage, while the margin reset reduces earnings cushion and makes sustained acceleration more important to future performance.

Higher Leverage Reduces Flexibility

Higher leverage leaves Danaher with less financial flexibility than in prior years, even though equity remains substantial. Additional debt can increase interest and refinancing exposure, constrain acquisition capacity, and reduce room to respond aggressively if end-market conditions weaken.

Danaher News

0R2B FAQ

What was Danaher’s price range in the past 12 months?
Danaher lowest share price was $159.95 and its highest was $244.50 in the past 12 months.
What is Danaher’s market cap?
Danaher’s market cap is $163.38B.
When is Danaher’s upcoming earnings report date?
Danaher’s upcoming earnings report date is Jan 27, 2027 which is in 87 days.
How were Danaher’s earnings last quarter?
Danaher released its earnings results on Oct 21, 2026. The company reported $2.11 earnings per share for the quarter, beating the consensus estimate of $1.917 by $0.193.
Is Danaher overvalued?
According to Wall Street analysts Danaher’s price is currently Undervalued.
Does Danaher pay dividends?
Danaher pays a Quarterly dividend of $0.4 which represents an annual dividend yield of 0.66%. See more information on Danaher dividends here
What is Danaher’s EPS estimate?
Danaher’s EPS estimate is 2.48.
How many shares outstanding does Danaher have?
Danaher has 703,530,800 shares outstanding.
What happened to Danaher’s price movement after its last earnings report?
Danaher reported an EPS of $2.11 in its last earnings report, beating expectations of $1.917. Following the earnings report the stock price went up 2.65%.
Which hedge fund is a major shareholder of Danaher?
Currently, no hedge funds are holding shares in GB:0R2B
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology